Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoxiang Zhengqi water navel paste vs oral administration in children with spleen and stomach diseases
ChiCTR2200062401Phase 4Recruiting
- Sponsor
- Jiangxi University of Traditional Chinese Medicine
- Start
- Jul 2022
- Countries
- 1
01
Overview
Phase 4, open-label trial of Huoxiang Zhengqi in spleen and stomach diseases (2 arms), sponsored by Jiangxi University of Traditional Chinese Medicine. Primary endpoints: TCM syndrome score, Therapeutic effect of spleen and stomach diseases and 2 more. Started Jul 2022; status: recruiting.
02
Drugs
Huoxiang Zhengqi
03
Conditions
spleen and stomach diseases
Beyond the preview
Go deeper on ChiCTR2200062401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062401.